{"id":"https://openalex.org/W2955405331","doi":"https://doi.org/10.1158/1538-7445.sabcs18-1012","title":"Abstract 1012: Selective estrogen receptor downregulators and immune checkpoint inhibitors in breast cancer immunotherapy","display_name":"Abstract 1012: Selective estrogen receptor downregulators and immune checkpoint inhibitors in breast cancer immunotherapy","publication_year":2019,"publication_date":"2019-07-01","ids":{"openalex":"https://openalex.org/W2955405331","doi":"https://doi.org/10.1158/1538-7445.sabcs18-1012","mag":"2955405331"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.sabcs18-1012","doi":"https://doi.org/10.1158/1538-7445.sabcs18-1012","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs18-1012","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Endocrinology","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068958299","display_name":"Diana C. M\u00e1rquez\u2010Garb\u00e1n","orcid":"https://orcid.org/0000-0002-4693-3063","observed_orcids":["https://orcid.org/0000-0002-4693-3063"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Diana C. M\u00e1rquez-Garban","raw_affiliation_strings":["UCLA, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCLA, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101474965","display_name":"Gang Deng","orcid":"https://orcid.org/0000-0002-3054-2957","observed_orcids":["https://orcid.org/0000-0002-3054-2957"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gang Deng","raw_affiliation_strings":["UCLA, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCLA, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111810751","display_name":"Begonya Comin-Anduix","orcid":"https://orcid.org/0000-0002-3618-9533","observed_orcids":["https://orcid.org/0000-0002-3618-9533"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Begonya Comin-Anduix","raw_affiliation_strings":["UCLA, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCLA, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087426878","display_name":"Alejandro J. Garcia","orcid":"https://orcid.org/0000-0001-9087-6193","observed_orcids":["https://orcid.org/0000-0001-9087-6193"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alejandro J. Garcia","raw_affiliation_strings":["UCLA, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCLA, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081368231","display_name":"Emelyine Diers","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emelyine Diers","raw_affiliation_strings":["UCLA, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCLA, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101791682","display_name":"Gaoyuan Ma","orcid":"https://orcid.org/0000-0002-6483-9062","observed_orcids":["https://orcid.org/0000-0002-6483-9062"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gaoyuan Ma","raw_affiliation_strings":["UCLA, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCLA, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018042582","display_name":"Nalo M. Hamilton","orcid":"https://orcid.org/0000-0002-6717-8079","observed_orcids":["https://orcid.org/0000-0002-6717-8079"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nalo Hamilton","raw_affiliation_strings":["UCLA, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCLA, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064589097","display_name":"Michael E. Jung","orcid":"https://orcid.org/0000-0003-1290-8588","observed_orcids":["https://orcid.org/0000-0003-1290-8588"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael E. Jung","raw_affiliation_strings":["UCLA, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCLA, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034694412","display_name":"Richard J. Pietras","orcid":"https://orcid.org/0000-0002-2846-3192","observed_orcids":["https://orcid.org/0000-0002-2846-3192"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard J. Pietras","raw_affiliation_strings":["UCLA, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCLA, Los Angeles, CA","institution_ids":["https://openalex.org/I161318765"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I161318765"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"1012","last_page":"1012"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.8598999977111816,"subfield":{"id":"https://openalex.org/subfields/1310","display_name":"Endocrinology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.8598999977111816,"subfield":{"id":"https://openalex.org/subfields/1310","display_name":"Endocrinology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.05779999867081642,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.04910000041127205,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/selective-estrogen-receptor-downregulators","display_name":"selective estrogen receptor downregulators","score":0.9350000023841858},{"id":"https://openalex.org/keywords/estrogen-receptor-alpha","display_name":"estrogen receptor alpha","score":0.718999981880188},{"id":"https://openalex.org/keywords/breast-cancer-immunotherapy","display_name":"breast cancer immunotherapy","score":0.8889999985694885},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9539999961853027},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9330000281333923},{"id":"https://openalex.org/keywords/fulvestrant","display_name":"fulvestrant","score":0.8529999852180481},{"id":"https://openalex.org/keywords/myeloid-derived-suppressor-cells","display_name":"myeloid-derived suppressor cells","score":0.9229999780654907},{"id":"https://openalex.org/keywords/endocrine-resistance","display_name":"endocrine therapy resistance","score":0.781000018119812},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5590000152587891},{"id":"https://openalex.org/keywords/mcf-7-xenografts","display_name":"MCF-7 xenografts","score":0.8019999861717224},{"id":"https://openalex.org/keywords/dendritic-cells","display_name":"dendritic cells","score":0.7889999747276306},{"id":"https://openalex.org/keywords/t-cells","display_name":"T cells","score":0.8159999847412109},{"id":"https://openalex.org/keywords/tumor-immunosuppression","display_name":"tumor immunosuppression","score":0.7319999933242798},{"id":"https://openalex.org/keywords/syngeneic-mouse-model","display_name":"syngeneic mouse model","score":0.722000002861023}],"concepts":[{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.7282401323318481},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6604876518249512},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.620539665222168},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5639169812202454},{"id":"https://openalex.org/C2777164284","wikidata":"https://www.wikidata.org/wiki/Q277954","display_name":"Estrogen","level":2,"score":0.5330848693847656},{"id":"https://openalex.org/C84606932","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Estrogen receptor","level":4,"score":0.5307407975196838},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.4781692624092102},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4763072729110718},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.47114959359169006},{"id":"https://openalex.org/C2910080358","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Oestrogen receptor","level":4,"score":0.4499713182449341},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4489235579967499},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4274791181087494},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.41255834698677063},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.39391815662384033},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2679729461669922}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.sabcs18-1012","doi":"https://doi.org/10.1158/1538-7445.sabcs18-1012","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs18-1012","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Endocrinology","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2953080297","https://openalex.org/W7148773897","https://openalex.org/W7221789962","https://openalex.org/W2612210035","https://openalex.org/W2598503582","https://openalex.org/W3009588484","https://openalex.org/W3186188353","https://openalex.org/W4200081636","https://openalex.org/W2494514989","https://openalex.org/W2580935506"],"abstract_inverted_index":{"Breast":[0],"cancers":[1,233],"(BC)":[2],"with":[3,22,51,58,147,199,290,302,322,328],"expression":[4],"of":[5,14,40,49,77,90,111,129,168,230,252,268,394],"estrogen":[6,380],"receptor-alpha":[7],"(ER\u03b1)":[8],"occur":[9],"in":[10,17,70,75,119,136,162,165,177,181,225,254,257,271,276,312,387],"more":[11,278],"than":[12],"70%":[13],"newly-diagnosed":[15],"patients":[16,50,57,327],"the":[18,41,166,249,395],"U.S.":[19],"Endocrine":[20],"therapy":[21],"antiestrogens":[23],"or":[24],"aromatase":[25],"inhibitors":[26,292,386],"is":[27,68,113],"an":[28,99],"important":[29],"intervention":[30],"for":[31,297,398],"BCs":[32],"that":[33,93,101,140,190,304,332],"express":[34],"ER\u03b1,":[35],"and":[36,54,74,124,212,223,273,314,352,383],"it":[37],"remains":[38],"one":[39],"most":[42,71,298],"effective":[43,296],"targeted":[44],"treatments.":[45],"However,":[46],"substantial":[47],"numbers":[48],"localized":[52],"disease,":[53],"almost":[55],"all":[56],"metastatic":[59],"BC,":[60],"become":[61],"resistant":[62,72],"to":[63,82,150,217,242,280,284,335],"current":[64,336],"endocrine":[65,337],"therapies.":[66],"ER\u03b1":[67,91,144],"present":[69],"BCs,":[73],"many":[76],"these":[78,141,153],"its":[79,116],"activity":[80],"continues":[81],"regulate":[83],"BC":[84,134,159,239,330],"growth.":[85],"Fulvestrant":[86],"represents":[87],"a":[88,126,182,228,266],"class":[89],"antagonists":[92],"elicit":[94],"selective":[95],"ER":[96,203],"downregulation":[97],"(SERDs),":[98],"action":[100],"helps":[102],"overcome":[103],"several":[104],"resistance":[105],"mechanisms.":[106],"Unfortunately,":[107],"full":[108],"antitumor":[109,250],"efficacy":[110,148],"fulvestrant":[112,196],"limited":[114],"by":[115,341],"poor":[117],"bioavailability":[118],"clinic.":[120],"We":[121],"have":[122],"designed":[123],"tested":[125],"new":[127,154,191],"generation":[128],"steroid-like":[130],"SERDs.":[131],"Using":[132],"ER\u03b1-positive":[133,158],"cells":[135,201,208,211],"vitro,":[137],"we":[138,247],"find":[139],"compounds":[142],"suppress":[143],"protein":[145],"levels":[146],"similar":[149],"fulvestrant.":[151],"Moreover,":[152],"SERDs":[155,192,253,303,320],"markedly":[156],"inhibit":[157],"cell":[160],"proliferation":[161],"vitro":[163],"even":[164],"presence":[167],"estradiol-17\u03b2.":[169],"In":[170,318],"vivo,":[171],"SERD-128":[172],"significantly":[173],"inhibits":[174],"tumor":[175,286],"growth":[176],"MCF-7":[178],"xenograft":[179],"models":[180],"dose-dependent":[183],"manner":[184],"(P<0.001).":[185],"Further,":[186],"our":[187],"findings":[188],"show":[189],"as":[193,195,205],"well":[194],"also":[197],"interact":[198],"immune":[200,221,243,306,384],"expressing":[202],"such":[204],"myeloid-derived":[206],"suppressor":[207],"(MDSC),":[209],"dendritic":[210],"T-lymphocytes.":[213],"Importantly,":[214],"MDSCs":[215],"act":[216],"protect":[218],"tumors":[219,272],"from":[220],"recognition":[222,307],"elimination":[224],"vivo.":[226],"Since":[227,288],"fraction":[229],"triple-negative":[231],"breast":[232,388],"(TNBC;":[234],"ER\u03b1-/PR-/HER2-)":[235],"but":[236],"not":[237,294],"other":[238,329],"subtypes":[240,331],"respond":[241],"checkpoint":[244,291,385],"inihbitors":[245],"(ICIs),":[246],"assessed":[248],"effects":[251],"murine":[255],"TNBCs":[256,275],"immune-competent,":[258],"syngeneic":[259],"mouse":[260],"models.":[261],"Notably,":[262],"SERD":[263],"treatment":[264,338],"induced":[265],"blockade":[267],"MDSC":[269],"populations":[270],"rendered":[274],"vivo":[277],"susceptible":[279],"ICIs,":[281],"thereby":[282],"leading":[283],"enhanced":[285],"killing.":[287],"monotherapy":[289],"has":[293],"been":[295],"TNBCs,":[299],"combination":[300],"therapies":[301],"enhance":[305],"may":[308,324],"increase":[309],"immunotherapy":[310,390],"responses":[311],"TNBC":[313],"improve":[315],"patient":[316],"survival.":[317],"addition,":[319],"combined":[321],"ICIs":[323],"potentially":[325],"benefit":[326],"are":[333],"unresponsive":[334],"strategies.":[339],"[Funded":[340],"Tower":[342],"Cancer":[343,399,413],"Research":[344,400],"Foundation-Jessica":[345],"M.":[346],"Berman":[347],"Fund,":[348],"NCI":[349],"U54":[350],"CA-14393":[351],"UCLA":[353],"Innovation":[354],"Fund].Citation":[355],"Format:":[356],"Diana":[357],"C.":[358],"M\u00e1rquez-Garban,":[359],"Gang":[360],"Deng,":[361],"Begonya":[362],"Comin-Anduix,":[363],"Alejandro":[364],"J.":[365,377],"Garcia,":[366],"Emelyine":[367],"Diers,":[368],"Gaoyuan":[369],"Ma,":[370],"Nalo":[371],"Hamilton,":[372],"Michael":[373],"E.":[374],"Jung,":[375],"Richard":[376],"Pietras.":[378],"Selective":[379],"receptor":[381],"downregulators":[382],"cancer":[389],"[abstract].":[391],"In:":[392],"Proceedings":[393],"American":[396],"Association":[397],"Annual":[401],"Meeting":[402],"2019;":[403],"2019":[404],"Mar":[405],"29-Apr":[406],"3;":[407],"Atlanta,":[408],"GA.":[409],"Philadelphia":[410],"(PA):":[411],"AACR;":[412],"Res":[414],"2019;79(13":[415],"Suppl):Abstract":[416],"nr":[417],"1012.":[418]},"counts_by_year":[],"updated_date":"2026-09-25T08:18:29.962427","created_date":"2019-07-12T00:00:00"}